OTHER INFORMATION.
+Added: (c) During the three months ended March 31, 2025, none of our officers or directors, as defined in Rule 16a-1(f),
+Added: informed us of the adoption , modification or termination of any “Rule 10b5-1 trading arrangement” or a “non-Rule 10b5-1
+Added: trading arrangement,” as those terms are defined in Item 408 of Regulation S-K.
The following exhibits are filed herewith:
10 unchanged sentences
Form of Investor Warrant dated May 16, 2022 (32)
+Added: Form of Voting Rights Proxy Agreement (58)
Collaboration Agreement dated December 29, 2015 (8)
68 unchanged sentences
Definitive License Agreement between the Company and ForSeeCon Eye Corporation (49)
−Removed: Definitive License Agreement between BioFirst Corporationand ForSeeCon
−Removed: Eye Corporation (49)
+Added: Definitive License Agreement between BioFirst Corporationand ForSeeCon Eye Corporation (49)
Form of Amendment (50)
5 unchanged sentences
Amendment to the Definitive License Agreement between the Company and ForSeeCon Eye Corporation (54)
−Removed: Amendment to the Definitive License Agreement between BioFirst Corporation
−Removed: and ForSeeCon Eye Corporation (54)
+Added: Amendment to the Definitive License Agreement between BioFirst Corporation and ForSeeCon Eye Corporation (54)
Amendment to the License Agreement between the Company and AiBtl BioPharma Inc.
1 unchanged sentence
and AiBtl BioPharma Inc.
+Added: Letter Agreement dated January 5, 2025 (56)
+Added: Land Transfer Plan dated March 31, 2025 (57)
+Added: Nominee Holding Agreement dated April 1, 2024 (57)
+Added: Land Lease Agreement dated April 1, 2024 (57)
+Added: Addendum to Definitive Licensing Agreement between ABVC and AiBtl dated March 11, 2025 (57)
+Added: Addendum to Definitive Licensing Agreement between BioLite and AiBtl dated March 11, 2025 (57)
+Added: Yunzhiyi Land Holding Agreement dated October 28, 2024 (57)
+Added: Form of Purchase Agreement (58)
Certifications pursuant to Rule 13a-14(a) or 15d-14(a) under the Securities Exchange Act of 1934, as amended, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.+
10 unchanged sentences
Inline XBRL Taxonomy Extension Presentation Linkbase Document.+
−Removed: Cover Page Interactive Data File (formatted as Inline XBRL and contained
−Removed: in Exhibit 101).
−Removed: accordance with SEC Release 33-8238, Exhibits 32.1 and 32.2 are being furnished and not filed.
+Added: Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).
+Added: In accordance with SEC Release 33-8238, Exhibits 32.1 and 32.2 are being furnished and not filed.
+Added: Filed herewith
Incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K, filed on February 16, 2016.
15 unchanged sentences
Incorporated by reference to Exhibit 10.3 to the Company’s Current Report on Form 8-K, filed on February 1, 2019.
−Removed: Incorporated by reference to Exhibit 10.2 to the Company’s Current Report on Form 8-K, filed on April 24, 2020.
+Added: Incorporated by reference to Exhibit 10.1 to the Company’s Current
+Added: Report on Form 8-K, filed on April 24, 2020.
Incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K, filed April 14, 2020.
2 unchanged sentences
Incorporated by reference to Exhibit 14.1 to the Company’s Amendment No.1 to Form S-1, filed on November 14, 2016.
−Removed: Incorporated by reference to 21.1 to the Company’s Form S-1,
−Removed: filed on September 13, 2016.
−Removed: Incorporated by reference to Exhibit 10.9 to the Company’s Annual
−Removed: Report on Form 10-K, filed May 15, 2020.
−Removed: Incorporated by reference to Exhibit 10.17 to the Company’s Annual
−Removed: Report on Form 10-K, filed March 16, 2021.
−Removed: Incorporated by reference to the Current Report on Form 8-K filed on
−Removed: November 5, 2020.
+Added: Incorporated by reference to 21.1 to the Company’s Form S-1, filed on September 13, 2016.
+Added: Incorporated by reference to Exhibit 10.9 to the Company’s Annual Report on Form 10-K, filed May 15, 2020.
+Added: Incorporated by reference to Exhibit 10.17 to the Company’s Annual Report on Form 10-K, filed March 16, 2021.
+Added: Incorporated by reference to the Current Report on Form 8-K filed on November 5, 2020.
Incorporated by reference to the Current Report on Form 8-K filed on June 8, 2021.
26 unchanged sentences
Incorporated by reference to the Company’s Current Report on Form 8-K, filed on June 25, 2024
−Removed: Pursuant to the requirements of the Securities
−Removed: Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
+Added: Incorporated by reference to the Company’s Current Report on Form 8-K, filed on January 6, 2025
+Added: Incorporated by reference to the Company’s Annual Report on Form 10-K, filed April 15, 2025
+Added: Incorporated by reference to the Company’s Current Report on Form 8-K, filed on April 30, 2025
+Added: Pursuant to the requirements of the Securities Exchange Act of 1934,
+Added: the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
ABVC BioPharma, Inc.
−Removed: November 14, 2024
+Added: April 30, 2025
/s/ Uttam Patil
2 unchanged sentences
ABVC BioPharma, Inc.
−Removed: November 14, 2024
+Added: April 30, 2025
/s/ Uttam Patil
2 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.